Documente Academic
Documente Profesional
Documente Cultură
(cefuroxime) rd y 3 generation (Cefotaxime, Ceftriaxone, Cefixime) y 3rd generation (Ceftazidime) Monobactams (Aztreonam) Carbapenems y Meropenem y Imipenem Sulfonamides
Bacterial coverage Gram (+) ORSA Greater gram (-) coverage More gram (-) coverage including Klebsiella, Pseudomonas, H. influenza, & anaerobes Gram (+) and gram (-) Gram (+), moderate gram (-)
Lack of coverage
Other Notes
Pseudomonas
Gram (+), Gram (-) including Hemophilis Gram (+), Gram (-) including some pseudomonas
Pseudomonas
Gram (+), Gram (-) including better Pseudomonas coverage Gram (-) including Pseudomonas Gram (+), Gram (-) Gram (+), less Gram (-) coverage than meropenem Gram (+), Gram (-)
Gram (+)
Quinolones nd y 2 generation (Ciprofloxacin, Ofloxacin) rd y 3 generation (Levofloxacin, Moxifloxacin, Gatifloxacin) Aminoglycosides (Kanamycin, Amakacin, Streptomycin, Tobramycin) Vancomycin Linezolid Quinupristin/Dalfopristin (Synercid) Daptomycin Macrolides (Erythromycin, Clarithromycin, Azithromycin) y Azithromycin
Gram (-) activity against Gram (+) nd S. pneumoniae more susceptible than to 2 generation Gram (-), aerobic bacteria Includes Pseudomonas Gram (+); ORSA & penicillin-resistant strains Vancomycin resistant bacteria (VRE); penicillinresistant pneumococci & Staph aureus Highly active against Streptococci (including drug-resistant strains); Main use: VRE Gram (+) bacteria: MRSA, VRE, penicillinresistant Streptococcus Gram (+)
Tetracyclines
Gram (+) Stronger gram (-) activity than Clarithromycin, erythromycin Gram (+), Gram (-), aerobic, anaerobic Generally more active against gram (+) bacteria